39.46
Schlusskurs vom Vortag:
$39.16
Offen:
$39.04
24-Stunden-Volumen:
2.42M
Relative Volume:
0.59
Marktkapitalisierung:
$16.73B
Einnahmen:
$2.31B
Nettoeinkommen (Verlust:
$1.66B
KGV:
17.18
EPS:
2.297
Netto-Cashflow:
$827.02M
1W Leistung:
+1.28%
1M Leistung:
+6.62%
6M Leistung:
+15.99%
1J Leistung:
+52.95%
Royalty Pharma Plc Stock (RPRX) Company Profile
Firmenname
Royalty Pharma Plc
Sektor
Branche
Telefon
(212) 883-0200
Adresse
110 EAST 59TH STREET, NEW YORK, NY
Vergleichen Sie RPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
RPRX
Royalty Pharma Plc
|
39.46 | 16.73B | 2.31B | 1.66B | 827.02M | 2.297 |
|
ARGX
Argen X Se Adr
|
918.53 | 57.24B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.52 | 110.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
201.62 | 42.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
363.92 | 41.68B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
725.34 | 74.02B | 14.25B | 4.58B | 3.88B | 41.77 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-30 | Eingeleitet | Goldman | Buy |
| 2025-05-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-06-03 | Herabstufung | UBS | Buy → Neutral |
| 2022-06-14 | Fortgesetzt | UBS | Buy |
| 2022-05-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2022-04-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-29 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-30 | Eingeleitet | Tigress Financial | Buy |
| 2020-11-09 | Hochstufung | UBS | Neutral → Buy |
| 2020-07-14 | Eingeleitet | Evercore ISI | In-line |
| 2020-07-13 | Eingeleitet | BofA Securities | Buy |
| 2020-07-13 | Eingeleitet | Citigroup | Neutral |
| 2020-07-13 | Eingeleitet | Cowen | Outperform |
| 2020-07-13 | Eingeleitet | Goldman | Neutral |
| 2020-07-13 | Eingeleitet | JP Morgan | Neutral |
| 2020-07-13 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Eingeleitet | SunTrust | Buy |
| 2020-07-13 | Eingeleitet | UBS | Neutral |
Alle ansehen
Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten
How Analyst Views on Royalty Pharma Are Shifting With Recent Acquisition and Growth Moves - Yahoo Finance
Will Royalty Pharma plc (RPD) stock maintain strong growthDividend Hike & Reliable Trade Execution Plans - newser.com
Vise Technologies Inc. Takes Position in Royalty Pharma PLC $RPRX - MarketBeat
Why Royalty Pharma plc (RPD) stock could break out in 20252025 Macro Impact & Technical Confirmation Alerts - newser.com
Ontario Teachers Pension Plan Board Makes New Investment in Royalty Pharma PLC $RPRX - MarketBeat
Published on: 2025-11-18 06:12:54 - newser.com
Will Royalty Pharma plc (RPD) stock hit Wall Street targetsOil Prices & Real-Time Stock Entry Alerts - newser.com
Is Royalty Pharma plc (RPD) stock attractive post correctionJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - newser.com
Top chart patterns to watch in Royalty Pharma plcPortfolio Return Summary & Long-Term Capital Growth Ideas - newser.com
Historical volatility pattern of Royalty Pharma plc visualizedJuly 2025 Catalysts & Safe Capital Investment Plans - newser.com
Forsta AP Fonden Reduces Stake in Royalty Pharma PLC $RPRX - MarketBeat
Geode Capital Management LLC Has $299.49 Million Position in Royalty Pharma PLC $RPRX - MarketBeat
What indicators show strength in Royalty Pharma plc2025 Macro Impact & Low Drawdown Momentum Ideas - newser.com
What analysts say about Royalty Pharma plc stockShort-Term Trading Alerts & Easy Tools to Analyze Your Investment Risk - earlytimes.in
What’s the recovery path for long term holders of Royalty Pharma plc - newser.com
Analyzing net buyer seller activity in Royalty Pharma plcJuly 2025 Pullbacks & High Accuracy Investment Signals - newser.com
What MACD signals say about Royalty Pharma plcTrade Risk Assessment & Low Risk High Reward Ideas - newser.com
Can Royalty Pharma plc stock rebound after recent weaknessPortfolio Performance Report & High Return Trade Opportunity Guides - newser.com
Royalty Pharma (NASDAQ:RPRX) Upgraded at Wall Street Zen - MarketBeat
Why Royalty Pharma plc (RPD) stock could outperform next yearMarket Rally & Free Safe Capital Growth Stock Tips - newser.com
Why Royalty Pharma plc (RPD) stock could rally stronglyJuly 2025 Reactions & Momentum Based Trading Ideas - newser.com
Is Royalty Pharma plc stock a safe investment in uncertain marketsWeekly Loss Report & Long-Term Capital Growth Strategies - newser.com
Why analysts remain bullish on Royalty Pharma plc stockDollar Strength & Long-Term Growth Portfolio Plans - newser.com
Applying chart zones and confluence areas to Royalty Pharma plcInsider Selling & Free Daily Entry Point Trade Alerts - newser.com
Quantitative breakdown of Royalty Pharma plc recent moveMarket Growth Report & Reliable Trade Execution Plans - newser.com
Is Royalty Pharma Plc's (NASDAQ:RPRX) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - 富途牛牛
Royalty Pharma: Guidance Raised Again, Platform Strength Intact -- Buy Reiterated (NASDAQ:RPRX) - Seeking Alpha
Why retail investors pile into Royalty Pharma plc stockWeekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
Is Royalty Pharma plc (RPD) stock a buy during volatile marketsVolume Spike & Verified Chart Pattern Signals - newser.com
Is Royalty Pharma plc stock a top momentum playQuarterly Market Review & Fast Gain Swing Alerts - newser.com
Monetta Financial Services Inc. Acquires New Shares in Royalty Pharma PLC $RPRX - MarketBeat
What drives Royalty Pharma plc stock priceResistance Breakout Alerts & Accelerated Capital Growth - earlytimes.in
How Royalty Pharma plc (RPD) stock performs in easing cyclesEarnings Growth Report & Community Trade Idea Sharing - newser.com
Mitsubishi UFJ Trust & Banking Corp Lowers Position in Royalty Pharma PLC $RPRX - MarketBeat
Jupiter Asset Management Ltd. Acquires 1,380,115 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance
Finanzdaten der Royalty Pharma Plc-Aktie (RPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Royalty Pharma Plc-Aktie (RPRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Norden Gregory | Director |
Aug 11 '25 |
Sale |
36.23 |
33,500 |
1,213,749 |
194,848 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):